Page last updated: 2024-09-03

etomoxir and nadp

etomoxir has been researched along with nadp in 1 studies

Compound Research Comparison

Studies (etomoxir)	Trials (etomoxir)	Recent Studies (post-2010) (etomoxir)	Studies (nadp)	Trials (nadp)	Recent Studies (post-2010) (nadp)
260	8	93	21,608	25	3,484

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Croteau, NJ; Ferrick, DA; Pike, LS; Smift, AL; Wu, M	1

Other Studies

1 other study(ies) available for etomoxir and nadp

Article	Year
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochimica et biophysica acta, 2011, Volume: 1807, Issue:6 Topics: Adenosine Triphosphate; Brain Neoplasms; Cell Death; Down-Regulation; Drug Evaluation, Preclinical; Epoxy Compounds; Fatty Acids; Glioblastoma; Humans; Hypoglycemic Agents; Models, Biological; NADP; Oxidation-Reduction; Reactive Oxygen Species; Tumor Cells, Cultured; Up-Regulation	2011

Article

Year

Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.

Biochimica et biophysica acta, 2011, Volume: 1807, Issue:6

Topics: Adenosine Triphosphate; Brain Neoplasms; Cell Death; Down-Regulation; Drug Evaluation, Preclinical; Epoxy Compounds; Fatty Acids; Glioblastoma; Humans; Hypoglycemic Agents; Models, Biological; NADP; Oxidation-Reduction; Reactive Oxygen Species; Tumor Cells, Cultured; Up-Regulation

2011